Wikidata

(Q63572521)

English

Comparison of Clinical Effects of Rituximab and Glatiramer Acetate in Primary Progressive Multiple Sclerosis Patients

clinical trial

In more languages

Statements

title
Comparison of Expanded Disability Status Scale, Gad-enhanced Brain Lesions, and Side Effects in Primary Progressive Multiple Sclerosis Patients on Rituximab and Glatiramer Acetate (English)
0 references
medical condition
sclerosis
0 references
multiple sclerosis
0 references
start time
1 December 2017
0 references
end time
1 February 2019
0 references
number of participants
84
0 references
research intervention
rituximab
0 references
glatiramer acetate
0 references
methylprednisolone
0 references
chlorpheniramine
0 references
minimum age
18 year
0 references
maximum age
55 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63572521&oldid=2143506451"